Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07117383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 12, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 2025 to Jan 2026
    • Primary and study completion dates: Nov 2025 to Mar 2026
    v3
  2. Interventions: ASP-001 (Drug), ASP-001.1 (Device), ASP-001.1 (Drug), Commercial Sildenafil and Sildenafil/Tadalafil Products (Drug) to ASP-001 (Drug), ASP-001.1 (Device), Commercial Sildenafil and Sildenafil/Tadalafil Products (Drug)
    • Study title shortened, about 5 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare how different sildenafil formulations are absorbed and tolerated in healthy adult males under fed conditions. The main questions it aims to answer are: Do Hezkue and Hezkue Turbo differ in absorption compared to other commercial sildenafil products? Are there any differences in safety or tolerability between the products? Researchers will compare multiple formulations to evaluate differences in drug absorption and side effects.
Trial Details
NCT Number NCT07117383
Lead Sponsor Aspargo Labs, Inc
Conditions
(from sponsor)		 Erectile Dysfunction
Related terms Erectile Dysfunction
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov